Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 3 · 75%Low 0 · 0%Moderate 1 · 25%High 0 · 0%

Active TB · HIV‐negative people at risk of TB infection1

It is very uncertain whether rifampicin changes active TB compared with isoniazid (very low certainty).

1 finding from 1 review

Active TB · HIV‐negative people at risk of TB infection1

It is very uncertain whether rifampicin plus isoniazid changes active TB compared with isoniazid (very low certainty).

1 finding from 1 review

Active TB · HIV‐negative people at risk of TB infection1

It is very uncertain whether rifampicin plus pyrazinamide changes active TB: compared with isoniazid (very low certainty).

1 finding from 1 review

Active TB · HIV‐negative people at risk of TB infection1

Rifapentine plus isoniazid weekly showed no clear difference in active TB compared with isoniazid daily (moderate certainty).

1 finding from 1 review